{"news_desk": "Business", "print_page": "5", "section_name": "Business Day", "subsection_name": "DealBook", "byline": {"original": "By CHAD BRAY", "person": [{"rank": 1, "role": "reported", "firstname": "Chad", "organization": "", "lastname": "BRAY"}]}, "abstract": "DealBook Online; Allergan, maker of Botox, says it will buy Kythera Biopharmaceuticals for $2.1 billion.", "type_of_material": "News", "word_count": "492", "lead_paragraph": "The deal will bolster the products of facial treatments at Allergan, the maker of Botox, by adding an injection for double chins recently approved for use in the United States.", "pub_date": "2015-06-18T00:00:00Z", "document_type": "article", "slideshow_credits": null, "headline": {"main": "Allergan to Buy Kythera Biopharmaceuticals for $2.1 Billion", "print_headline": "Allergan Deal"}, "snippet": "The deal will bolster the products of facial treatments at Allergan, the maker of Botox, by adding an injection for double chins recently approved for use in the United States.", "multimedia": [], "web_url": "http://www.nytimes.com/2015/06/18/business/dealbook/allergan-to-buy-kythera-biopharmaceuticals-for-2-1-billion.html", "keywords": [{"rank": "1", "is_major": "Y", "value": "Allergan Inc", "name": "organizations"}, {"rank": "2", "is_major": "Y", "value": "Kythera Biopharmaceuticals Inc.", "name": "organizations"}, {"rank": "3", "is_major": "N", "value": "Mergers, Acquisitions and Divestitures", "name": "subject"}, {"rank": "4", "is_major": "N", "value": "Botox (Drug)", "name": "subject"}, {"rank": "5", "is_major": "N", "value": "Drugs (Pharmaceuticals)", "name": "subject"}, {"rank": "6", "is_major": "N", "value": "Stocks and Bonds", "name": "subject"}, {"rank": "7", "is_major": "N", "value": "Food and Drug Administration", "name": "organizations"}, {"rank": "8", "is_major": "N", "value": "Saunders, Brent", "name": "persons"}], "blog": [], "_id": "55816fa438f0d81a607270aa", "source": "The New York Times"}